SLC1A5 and hepatocellular carcinoma: SLC1A5/ASCT2 is the primary Na+-dependent glutamine transporter, whose expression is significantly higher in HCC tumor tissues compared to adjacent non-tumor tissues, and positively correlated with tumor size, making it a potential prognostic indicator (189).